Evidence map›Paper›PMID 36570444›Full record

ArticleFrontiers in neurology2022

Ting-Wei Liao, Chih-Ying Chao, Yih-Ru Wu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Characterization of aMolecular genetics and metabolism reports · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ting-Wei LiaoDepartment of Neurology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Chih-Ying ChaoDepartment of Neurology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Yih-Ru WuDepartment of Neurology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Linkou Chang Gung Memorial Hospital · TWChang Gung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: A recent Taiwanese study reported variants of the ubiquinol-cytochrome c reductase core protein 1 ( Method: This study involved 107 participants (98 with early-onset PD and nine with familial PD). All Results: Three missense variants (c.643G > C, p.D215H; c.800C > G, p.P267R, and c.923A > G, p.N308S) and seven rare variants were identified. No significant differences in the missense-variant carrier frequency were noted between our cohort and individuals in the Taiwan Biobank. Furthermore, no significant associations were noted between the variants and the risk of PD. Conclusions: Our study is not supporting a role of

Indexed as

early-onsetfamilialparkinsonismParkinson's diseaseubiquinol-cytochrome C reductase core protein 1 (UQCRC1)

Identifiers

PMID36570444
PMCPMC9780373
OpenAlexW4311948012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.